SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Large pharma companies at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
7 large pharma companies are at SNO 2026 — 15 presentations on the program. Most represented: Jazz Pharmaceuticals (2 on the program), Servier (2 on the program), Alexion, AstraZeneca Rare Disease (1 on the program). 2 of them have their own page in this guide. As of Nov 12, 2026.
Topic
Top represented
Showing 1–7 of 7 organizations
| Organization | SNO 2026 Attendance |
|---|---|
Jazz Pharmaceuticals Dublin, Ireland | ◆Platinum Supporter |
A biopharmaceutical company developing and marketing medicines, including therapies used in neuro-oncology. | Talk Fri Nov 13 7–8:15am Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 7–8:15am Talk Sat Nov 14 3:19–3:24pm Session Sat Nov 14 6–7pm |
Servier Suresnes, France | ◆Platinum Supporter |
An international pharmaceutical company developing and marketing medicines, including cancer therapies. | Talk Fri Nov 13 7–8:15am Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 7–8:15am Talk Sat Nov 14 10:15–11:15am |
Alexion, AstraZeneca Rare Disease Boston, MA | ◆Platinum Supporter |
A biopharmaceutical company developing treatments for rare diseases, including therapies relevant to neurofibromatosis. | Talk Fri Nov 13 7–8:15am Talk Fri Nov 13 6–7:15pm |
Takeda Tokyo, Japan | |
A global pharmaceutical company developing and marketing medicines, including treatments relevant to oncology. | Session Thu Nov 12 8:40–10:50am |
Daiichi Sankyo Tokyo, Japan | ◇Contributing Supporter |
A global pharmaceutical company developing and marketing medicines, including oncology therapies. | |
AstraZeneca Cambridge, UK | |
A global biopharmaceutical company whose medicines span oncology, rare disease, respiratory and cardiovascular care. | |
Medexus Pharma Toronto, Canada | ◇Contributing Supporter |
A pharmaceutical company that develops and commercializes specialty medicines, including treatments relevant to oncology. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Find buyers from large pharma companies
Tell us what you sell and we’ll find the people at these large pharma companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SNO 2026 by
Organization type
Topic
- Tumor biology: signaling, metabolism, stem cells and the tumor microenvironment 106
- Cancer neuroscience: how neurons and brain tumors interact 54
- Immunobiology, immunotherapy and cell therapies 64
- Experimental therapeutics, drug discovery and resistance, drug delivery and tumor models 105
- Clinical trials, trial design and trials in progress 99
- Molecular pathology, tumor classification and (epi)genomics 102
- Biomarkers and liquid biopsy 53
- Neuroimaging, PET and response assessment 62
- Neurosurgery and surgical therapies 41
- Radiotherapy, radiobiology and radiopharmaceuticals 49
- Pediatric and adolescent and young adult (AYA) brain tumors 55
- Brain and leptomeningeal metastases 27
- Rare CNS tumors and tumor predisposition syndromes 34
- CNS lymphoma and neurohematology 13
- Survivorship, quality of life, cognition, neurologic complications and palliative care 105
- Health disparities, epidemiology and quality improvement 58
Everyone
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction